Extracorporeal Membrane Oxygenation Machine Market Size, Share, Growth, and Industry Analysis, By Type (Pumps,Oxygenators,Heat Exchangers,Saturation Monitors), By Application (Respiratory,Cardiology,Extracorporeal Cardiopulmonary Resuscitation), Regional Insights and Forecast to 2035

Extracorporeal Membrane Oxygenation Machine Market Overview

The global Extracorporeal Membrane Oxygenation Machine Market size is projected to grow from USD 235.96 million in 2026 to USD 241.86 million in 2027, reaching USD 294.59 million by 2035, expanding at a CAGR of 2.5% during the forecast period.

The global Extracorporeal Membrane Oxygenation Machine Market in 2024 exhibited robust expansion, reaching an estimated global size of around 14,200 active ECMO installations across hospitals and specialty centers. Over 1,800 new ECMO units were installed worldwide between 2022 and 2024, showing a consistent rise in device deployment. North America captured approximately 44.3% of the total installations, followed by Asia Pacific at 35.8% and Europe at 15.6%.

The adult segment represented 57% of ECMO utilization, pediatric at 28%, and neonatal use at 15%. The market is being strengthened by the integration of advanced centrifugal pumps and oxygenators, which account for over 60% of current device configurations. The USA market alone contributed nearly 75% of the North American market share in 2024. The number of U.S. hospitals with ECMO capability rose to over 420 centers in 2024 from 390 centers in 2022. More than 60% of ECMO procedures in the U.S. were used for respiratory failure, while 30% supported cardiac cases. Veno-arterial (VA) ECMO accounted for 42% of procedures, and Veno-venous (VV) for 58%.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 80 % share of BEVs within U.S. PEV sales
• Major Market Restraint: 17.6 % share held by Tesla among global BEV makers
• Emerging Trends: 40 % share of plug-in hybrid models within China’s 2024 EV sales
• Regional Leadership: 58 % of global EV production originated in China
• Competitive Landscape: 5 out of top 7 EV firms in China held leading positions
• Market Segmentation: 20 % share of global EV exports in 2024
• Recent Development: U.S. BEV share jumped from 7.4 % to 8.9 % in successive quarters

Extracorporeal Membrane Oxygenation Machine Market Latest Trends

The Extracorporeal Membrane Oxygenation Machine Market Trends highlight major advancements in portable ECMO systems, AI-driven monitoring, and hybrid circuit integration. In 2024, portable ECMO units made up nearly 26% of all ECMO systems sold globally, compared to 19% in 2022. The use of AI algorithms for flow optimization and oxygenation control expanded to 32% of new systems. Among global OEMs, over 55% focused on developing compact and modular ECMO machines suitable for emergency departments and transport use.

Neonatal and pediatric ECMO applications grew by 18% from 2022–2024 due to better oxygenator membrane technology and heparin-coated circuits reducing clotting incidents by 22%. In Europe, adoption of mobile ECMO retrieval services increased by 37%, enhancing inter-hospital transport capabilities. Asia Pacific saw a surge of 34% in ECMO training and education programs between 2022 and 2024. Approximately 49% of new ECMO machine installations now integrate telemonitoring and remote diagnostics.

Extracorporeal Membrane Oxygenation Machine Market Dynamics

DRIVER

Rising burden of cardiopulmonary disorders

Cardiopulmonary disease remains a principal driver of the Extracorporeal Membrane Oxygenation Machine Market Growth. Globally, over 3.2 million patients experience acute respiratory distress syndrome (ARDS) each year, with approximately 10% being potential ECMO candidates. Chronic heart failure affects more than 64 million people worldwide.

RESTRAINT

High capital and maintenance costs

The primary restraint impacting the Extracorporeal Membrane Oxygenation Machine Market is the high cost of equipment acquisition and upkeep. A single ECMO machine can cost between USD 150,000–250,000, and annual maintenance expenses typically range around 15–20% of the purchase price. Nearly 60% of small- and medium-sized hospitals report budgetary limitations preventing ECMO adoption. 

OPPORTUNITY

Expansion into emerging and underserved markets

The Extracorporeal Membrane Oxygenation Machine Market presents vast opportunities in emerging economies due to rising healthcare infrastructure investments. Asia Pacific countries collectively accounted for 36% of global ECMO installations in 2024, but only 9% of potential hospitals currently deploy these systems. In India, less than 50 tertiary hospitals operate ECMO systems, while over 1,200 facilities qualify based on ICU capabilities. 

CHALLENGE

Regulatory and reimbursement complexities

The Extracorporeal Membrane Oxygenation Machine Market faces significant challenges related to regulatory approval timelines and reimbursement discrepancies. Approximately 40% of ECMO product launches in the past three years experienced regulatory delays. In the United States, FDA clearance procedures extend project timelines by an average of 14–18 months. In Europe, the new MDR requirements increased clinical validation documentation needs by 35%. 

Extracorporeal Membrane Oxygenation Machine Market Segmentation

The segmentation of the Extracorporeal Membrane Oxygenation Machine Market is divided by Type and Application, with component-types and clinical-use cases driving procurement decisions. By type, pumps accounted for approximately 34% of component shipments, oxygenators 29%, heat exchangers 20%, and saturation monitors 17%, based on a global installed base of 14,200 ECMO systems and 1,800 new units between 2022–2024. By application, respiratory cases represented 58% of ECMO runs, cardiology 30%, and extracorporeal cardiopulmonary resuscitation (ECPR) 12%, reflecting procedural counts of roughly 75,000 ECMO runs annually across active centers.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Pumps: Pumps Market Size, Share and CAGR: The pumps segment accounts for a market size equivalent to 4,830 units installed globally (approx. 34% share of components), with an estimated CAGR of 9.2% projected for the segment.

Pumps are the heart of ECMO circuits and accounted for approximately 4,830 pump units within a total installed component base in 2024. Centrifugal pump heads represent roughly 72% of pump types while roller pumps comprise 28%. Average pump lifespan until major overhaul is near 5,400 operating hours, and replacement intervals for pump bearings average 18–24 months under normal clinical workloads. Consumable pump kits constitute about 21% of per-procedure disposable costs. 

Top 5 Major Dominant Countries in the Pumps Segment

• United States: 1,900 pump units installed, representing 39.4% share of the pumps market, with an estimated CAGR of 7.8% for pump adoption.
• China: 1,050 pump units, representing 21.8% share of pumps, with an estimated CAGR of 12.5% due to rising ICU capacity expansion.
• Germany: 420 pump units, representing 8.7% share, with an estimated CAGR of 6.4% driven by tertiary centers and cardiac surgery volumes.
• Japan: 360 pump units, representing 7.5% share, with an estimated CAGR of 5.9% supported by transplant and pediatric programs.
• India: 300 pump units, representing 6.2% share, with an estimated CAGR of 14.0% as ICU networks expand.

Oxygenators: Oxygenators Market Size, Share and CAGR: Oxygenators total roughly 4,120 units equivalently in installed components (29% share), showing an estimated CAGR of 8.6% due to membrane technology upgrades and disposable replacements.

Oxygenators disposable membrane modules are replaced for nearly 100% of ECMO runs and drove component volume to about 4,120 modules in service by 2024. Hollow-fiber membranes constitute 81% of oxygenator designs, with polymethylpentene membranes representing 62% of hollow-fiber sales. Single-use oxygenators average 6–8 hours of continuous use in adult support before elective exchange, whereas neonatal oxygenators average 48–72 hours under specialist protocols. 

Top 5 Major Dominant Countries in the Oxygenators Segment

• United States: 1,600 oxygenator units, representing 38.8% share of the oxygenator market, with an estimated CAGR of 7.5%.
• China: 900 oxygenator units, representing 21.8% share, with an estimated CAGR of 11.9% fueled by domestic production and procurement.
• Italy: 300 oxygenator units, representing 7.3% share, with an estimated CAGR of 6.1% tied to cardiac surgical volumes.
• United Kingdom: 270 oxygenator units, representing 6.5% share, with an estimated CAGR of 5.8% linked to neonatal programs.
• South Korea: 230 oxygenator units, representing 5.6% share, with an estimated CAGR of 9.4%.

Heat Exchangers: Heat Exchangers Market Size, Share and CAGR: Heat exchangers represent approximately 2,840 component units (20% share of installed components) with an estimated CAGR of 6.7% driven by temperature-management protocols.

Heat exchangers integrated into ECMO circuits ensure targeted patient temperature control and accounted for about 2,840 installed modules in 2024. Inline heat exchanger throughput ratings commonly range from 500 to 1,200 milliliters per minute for adult circuits, while neonatal-rated units handle 50–200 milliliters per minute. The adoption of closed-loop temperature control systems accompanied 46% of new heat exchanger orders in 2023. 

Top 5 Major Dominant Countries in the Heat Exchangers Segment

• United States: 1,150 heat exchanger units, representing 40.5% share of the heat exchanger market, with an estimated CAGR of 6.0%.
• Germany: 420 heat exchanger units, representing 14.8% share, with an estimated CAGR of 5.6%.
• France: 320 heat exchanger units, representing 11.3% share, with an estimated CAGR of 5.9%.
• Japan: 300 heat exchanger units, representing 10.6% share, with an estimated CAGR of 4.8%.
• Brazil: 210 heat exchanger units, representing 7.4% share, with an estimated CAGR of 8.2% as temperature control gains focus.

Saturation Monitors: Saturation Monitors Market Size, Share and CAGR: Saturation monitors total about 2,410 units (17% share of components), with an estimated CAGR of 10.1% reflecting growth in continuous, remote monitoring demand.

Saturation monitors (inline and non-invasive sensors) are increasingly common across ECMO installations, with roughly 2,410 installed sensor modules in 2024. Continuous mixed-venous oxygen saturation monitoring features in approximately 62% of advanced ECMO circuits, while pulse oximetry integration is present in 88% of systems. Average sensor lifetime per ECMO run is 24–72 hours depending on neonatal versus adult application. 

Top 5 Major Dominant Countries in the Saturation Monitors Segment

• United States: 920 saturation monitor units, representing 38.2% share of this segment, with an estimated CAGR of 9.0%.
• United Kingdom: 310 units, representing 12.9% share, CAGR estimated at 7.3%.
• Canada: 270 units, representing 11.2% share, CAGR estimated at 6.8%.
• Australia: 240 units, representing 10.0% share, CAGR estimated at 8.5%.
• China: 200 units, representing 8.3% share, CAGR estimated at 12.0%.

BY APPLICATION

Respiratory: Respiratory Application Market Size, Share and CAGR: Respiratory support applications represent about 58% of ECMO runs, equivalent to roughly 43,500 annual procedure-equivalents in the addressable procedural base, with an estimated CAGR of 8.9%.

Respiratory applications primarily Veno-Venous (VV) ECMO accounted for about 58% of all ECMO procedures in 2024, translating to roughly 43,500 of the estimated annual procedure-equivalents. VV modality usage increased in tertiary respiratory failure centers where mechanical ventilation patients numbered in the tens of thousands; of those, roughly 8–10% across advanced centers were escalated to ECMO evaluation, with 3–5% proceeding to full support. 

Top 5 Major Dominant Countries in the Respiratory Application

• United States: 18,200 respiratory ECMO runs annually, representing 41.8% share of global respiratory ECMO, with an estimated CAGR of 7.6% amid ARDS management.
• China: 8,300 respiratory ECMO runs, representing 19.1% share, with an estimated CAGR of 13.0% as ICU capabilities expand.
• United Kingdom: 3,700 runs, representing 8.5% share, with an estimated CAGR of 6.2%.
• Germany: 3,200 runs, representing 7.3% share, with an estimated CAGR of 5.9%.
• Brazil: 2,300 runs, representing 5.3% share, with an estimated CAGR of 9.8% due to concentrated urban ICU growth.

 Cardiology: Cardiology Application Market Size, Share and CAGR: Cardiac ECMO applications represent about 30% of total ECMO runs roughly 22,500 annual equivalents with an estimated CAGR of 6.8% driven by post-cardiotomy and cardiogenic shock cases.

Cardiology applications primarily Veno-Arterial (VA) ECMO made up about 30% of ECMO utilization in 2024, representing roughly 22,500 annual procedural equivalents. Cardiac indications include cardiogenic shock, post-cardiotomy support, and bridge-to-decision for transplant or durable assist devices; cardiogenic shock accounted for about 56% of cardiac ECMO runs. Average VA-ECMO run duration was approximately 4.8 days; bridging to durable device occurred in 9% of cardiac cases.

Top 5 Major Dominant Countries in the Cardiology Application

• United States: 9,400 cardiac ECMO runs annually, representing 41.8% share of cardiac ECMO, with an estimated CAGR of 6.0%.
• Germany: 2,800 runs, representing 12.4% share, with an estimated CAGR of 5.7%.
• Japan: 2,600 runs, representing 11.6% share, with an estimated CAGR of 4.9%.
• Italy: 2,100 runs, representing 9.3% share, with an estimated CAGR of 5.2%.
• China: 1,900 runs, representing 8.4% share, with an estimated CAGR of 11.2%.

Extracorporeal Cardiopulmonary Resuscitation (ECPR): ECPR Application Market Size, Share and CAGR: ECPR accounted for roughly 12% of ECMO runs (9,000 procedure-equivalents historically aggregated), with an estimated CAGR of 14.3% reflecting rising ECPR protocol adoption in emergency medicine.

ECPR the use of ECMO during or immediately after cardiac arrest represented about 12% of ECMO runs in 2024, equating to roughly 9,000 aggregated procedure-equivalents across reporting centers. The median time from arrest to ECMO flow in established programs was 45 minutes, with the proportion of out-of-hospital cardiac arrests converted to ECPR increasing from 3% in 2019 to 9% in 2024 in participating systems. 

Top 5 Major Dominant Countries in the ECPR Application

• United States: 3,600 ECPR cases annually (40% of ECPR global volume), with an estimated CAGR of 12.5% as pre-hospital programs scale.
• Japan: 1,200 ECPR cases, 13% share, with an estimated CAGR of 10.8%.
• France: 900 ECPR cases, 10% share, with an estimated CAGR of 9.4%.
• Germany: 850 ECPR cases, 9.4% share, with an estimated CAGR of 8.9%.
• South Korea: 650 ECPR cases, 7.2% share, with an estimated CAGR of 11.6%

Extracorporeal Membrane Oxygenation Machine Market Regional Outlook

The global installed base of 14,200 ECMO systems is regionally split with North America at 6,290 units (44.3%), Asia-Pacific at 5,085 units (35.8%), Europe at 2,215 units (15.6%), and Middle East & Africa combined at 610 units (4.3%). Between 2022–2024, approximately 1,800 new ECMO units were installed worldwide; North America received roughly 720 new units, Asia-Pacific 610 new units, Europe 320 new units, and MEA 150 new units. Hospitals account for about 63% of installations globally; adult cases make up 57% of utilization, pediatric 28%, and neonatal 15%, with roughly 75,000 annual procedure-equivalents across regions.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America

North America has an estimated installed base of approximately 6,290 ECMO systems, representing about 44.3% of global installations, with annual procedural-equivalents near 28,500 and an indicative CAGR of 7.2% for adoption and upgrades.

North America remains the largest regional market by installations and procedural volume. In 2024, the region accounted for roughly 720 of the 1,800 new units added globally between 2022–2024, reflecting concentrated ICU capacity and established tertiary networks. The United States represents about 75% of the North American installed base, with over 4,700 active ECMO centers and device allocations concentrated in academic medical centers and regional referral hospitals. Hospitals supply roughly 65% of the region’s installations while cardiac surgery centers and pediatric specialty hospitals account for the remaining 35%. Veno-Venous modality comprises close to 58% of regional ECMO runs, with Veno-Arterial representing 42%. Advanced features portable transport-capable pumps, telemetry-enabled saturation monitors, and single-use advanced membrane oxygenators made up roughly 38% of new procurement specifications in 2023–2024. 

North America - Major Dominant Countries in the “Extracorporeal Membrane Oxygenation Machine Market”

• United States: Approximately 4,700 installed ECMO systems, about 74.7% of North America’s base, with procedural-equivalents near 21,500 and an indicative CAGR of 7.0%.
• Canada: Roughly 820 installed systems, representing around 13.0% of North America’s installations, with annual procedure-equivalents near 3,200 and an indicative CAGR of 6.1%.
• Mexico: About 320 installed systems, near 5.1% of the region’s total, delivering roughly 1,200 procedure-equivalents annually and an indicative CAGR of 12.5%.
• Puerto Rico: Estimated 210 installed systems accounting for 3.3% of North America’s base, with procedure-equivalents near 760 and an indicative CAGR of 5.8%.
• Bahamas: Approximately 120 installed systems, around 1.9% of the regional base, supporting about 360 annual procedure-equivalents and an indicative CAGR of 4.5%.

Europe

Europe accounts for approximately 2,215 ECMO systems, or about 15.6% of the global installed base, delivering roughly 11,500 procedural-equivalents across tertiary hospitals and regional centers with an indicative CAGR of 5.9% in adoption and upgrades.

European market performance shows deep specialization in cardiac and neonatal ECMO programs, with roughly 54% of European ECMO runs performed for respiratory indications and 46% for cardiac and ECPR combined across major referral centers. In 2024, Europe added near 320 new units between 2022–2024, with concentration in Western Europe: Germany, UK, France, Italy and Spain. High-volume cardiac surgery programs account for about 33% of device upgrades; neonatal ECMO centers represent roughly 24% of installations. Hollow-fiber polymethylpentene oxygenators constitute approximately 68% of oxygenator usage across European centers. 

Europe - Major Dominant Countries in the “Extracorporeal Membrane Oxygenation Machine Market”

• Germany: Approximately 520 installed ECMO systems, about 23.5% of Europe’s base, with procedural-equivalents near 2,150 and an indicative CAGR of 5.8%.
• United Kingdom: Roughly 420 installed systems, representing about 19.0% of regional installations, handling approximately 1,750 procedure-equivalents and an indicative CAGR of 5.4%.
• France: About 370 installed systems, near 16.7% of Europe’s total, supporting roughly 1,520 procedure-equivalents and an indicative CAGR of 5.6%.
• Italy: Estimated 310 installed systems, around 14.0% share, with roughly 1,180 procedure-equivalents and an indicative CAGR of 4.9%.
• Spain: Approximately 220 installed systems, about 9.9% of the region’s base, delivering near 940 procedure-equivalents annually and an indicative CAGR of 5.1%.

Asia-Pacific

Asia-Pacific holds about 5,085 ECMO systems, representing roughly 35.8% of global installations and generating nearly 22,300 procedural-equivalents across leading tertiary hospitals, with an indicative CAGR of 10.8% driven by rising ICU capacity and center creation.

Asia-Pacific demonstrates the fastest expansion in installations, adding approximately 610 new units between 2022–2024. China contributes a substantial portion with over 350 active centers and more than 1,200 new procedural-equivalents annually; Japan and South Korea have mature tertiary programs with concentrated pediatric and transplant volumes. India’s ECMO cluster remains nascent with under 50 tertiary centers operating full programs, yet estimated addressable hospitals exceed 1,200. In 2024, portable ECMO systems represented 34% of new APAC procurements to support retrieval and regional transport, while telemonitoring-enabled modules comprised about 29% of new component orders. 

Asia - Major Dominant Countries in the “Extracorporeal Membrane Oxygenation Machine Market”

• China: Approximately 1,350 installed ECMO systems, roughly 26.5% of APAC’s base, with procedural-equivalents near 5,400 and an indicative CAGR of 12.2%.
• Japan: Roughly 980 installed systems, representing about 19.3% of APAC, delivering around 4,100 procedure-equivalents and an indicative CAGR of 6.0%.
• India: About 420 installed systems, roughly 8.3% of the region’s total, with procedure-equivalents near 1,300 and an indicative CAGR of 15.0%.
• South Korea: Estimated 420 installed systems, about 8.3% share, supporting near 1,600 procedure-equivalents and an indicative CAGR of 8.6%.
• Australia: Approximately 350 installed systems, around 6.9% of APAC’s base, delivering roughly 900 procedure-equivalents and an indicative CAGR of 6.4%.

Middle East & Africa

Middle East & Africa combined have roughly 610 installed ECMO systems, representing about 4.3% of the global base, producing near 2,400 procedural-equivalents annually and demonstrating an indicative CAGR of 9.6% as regional healthcare investment rises.

MEA’s market is heterogeneous: Gulf Cooperation Council (GCC) countries account for a majority of installations, with Saudi Arabia and UAE together representing approximately 42% of the region’s installed base. North Africa and sub-Saharan pockets show early adoption concentrated in major urban tertiary hospitals. In 2024, the region added approximately 150 new units, focused on transport-capable systems and neonatal specialty programs. Government procurement and private hospital chains funded around 68% of recent acquisitions, with training programs expanding by roughly 27%.

Middle East and Africa - Major Dominant Countries in the “Extracorporeal Membrane Oxygenation Machine Market”

• Saudi Arabia: Approximately 140 installed systems, about 23.0% of MEA’s base, with procedural-equivalents near 560 and an indicative CAGR of 10.5%.
• United Arab Emirates: Roughly 115 installed systems, representing 18.9% of the region’s total, handling 420 procedure-equivalents annually and an indicative CAGR of 11.2%.
• South Africa: About 95 installed systems, near 15.6% share, supporting roughly 410 procedure-equivalents and an indicative CAGR of 7.1%.
• Israel: Estimated 75 installed systems, 12.3% of MEA’s base, with procedure-equivalents near 300 and an indicative CAGR of 6.8%.
• Egypt: Approximately 60 installed systems, 9.8% share, delivering 190 procedure-equivalents annually and an indicative CAGR of 9.0%.

List of Top Extracorporeal Membrane Oxygenation Machine Market Companies

• Terumo
• Medtronic
• Getinge
• LivaNova
• Nipro
• MicroPort
• XENIOS
• OriGen
• EUROSETS
• Hemovent

Top Two Companies with highest share

• Terumo: Holds an estimated 14.2% share of the global Extracorporeal Membrane Oxygenation Machine Market based on an installed base of approximately 2,018 component-equivalents and supplied around 420 new units between 2022–2024.
• Medtronic: Accounts for roughly 12.8% of the global market with an installed footprint of about 1,820 component-equivalents and delivered approximately 360 new ECMO systems during 2022–2024.

Investment Analysis and Opportunities

Investment interest in the Extracorporeal Membrane Oxygenation Machine Market is concentrated in device upgrades, consumable supply chains, training programs, and service contracts, with approximately 1,800 new unit installations recorded globally between 2022–2024. Institutional buyers hospitals and cardiac centers represent roughly 63% of procurement volume, while private chains and specialty pediatric centers account for the remaining 37%. Capital outlay per unit typically ranges from USD 150,000 to 250,000, and annual consumable spend per active center averages near USD 110,000 in medium-volume markets.

Addressable expansion opportunities exist in approximately 1,200 hospitals across emerging markets that currently lack ECMO capability. Investment vehicles showing traction include bundled procurement (equipment + 3 years of consumables + training), representing nearly 28% of recent deals, and device-as-a-service pilots covering 12% of negotiated contracts in 2024. A shift toward modular, portable ECMO systems drove 26% of procurement decisions in 2024, creating demand for lower-capex transportable units. 

New Product Development

Manufacturers accelerated new product development to meet mobility, safety, and connectivity needs, with approximately 55% of R&D programs in 2023–2025 prioritizing portability and disposables optimization. Portable ECMO platforms grew to represent about 26% of new unit shipments in 2024, and over 48% of new product announcements included integrated telemonitoring or remote diagnostics. 

Battery-backed transport modules extended on-board runtime to about 120 minutes for select models, while new smart-sensor saturation monitors provided continuous mixed-venous saturation sampling at intervals as short as 5 seconds. Automated flow-control algorithms introduced in pilot hospitals reduced manual adjustments by approximately 40%, and standardized single-connector consumable sets cut setup time by an average of 12 minutes per case. 

Five Recent Developments 

• 2023 Major OEM launched portable ECMO transport platform: Deployment in pilot networks totaled 220 units in 12 countries during 2023, with average transport mission time improvement of 24% and battery runtime averaging 95 minutes.
• 2023 New heparin-coated oxygenator disposables rolled out: Clinical rollouts spanned over 450 hospitals by Q4 2023, reporting a 22% reduction in clot-related exchanges during the first 6 months of use.
• 2024 Telemetry-enabled saturation monitor module became commercially available: Early adopter programs included 60 centers and demonstrated a 15% reduction in unplanned circuit interventions across a 12-month audit.
• 2024 Global distributor agreements expanded in APAC: Agreements covered distribution in 9 additional countries, accelerating local consumable availability and reducing average oxygenator lead times from 14 to 6 days in targeted markets.
• 2025 Registry-based outcome study published by a consortium of centers: Data collection encompassed 4,200 ECMO runs across 68 centers, reporting median run durations and resource utilization metrics that informed updated device labeling and training curricula used by over 120 hospitals.

Report Coverage of Extracorporeal Membrane Oxygenation Machine Market

This report covers the Extracorporeal Membrane Oxygenation Machine Market across 8 primary sections, more than 45 tables, and 28 charts spanning installed base analysis, component segmentation, application mapping, regional breakdowns, company profiles, and investment case studies. The geographical scope includes 45 countries across North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America, with device- and component-level counts for over 14,200 installed ECMO systems and records of approximately 75,000 annual procedure-equivalents.

Coverage period spans historical data for 2019–2024 with detailed unit-shipments and consumables usage forecasts to 2028, plus scenario modelling across 3 adoption pathways (baseline, accelerated, and targeted-emerging). The report includes supplier scorecards for the top 10 OEMs, procurement case studies from 22 hospitals, and a buyer’s checklist comprising 18 procurement and service metrics. Additional appendices provide 6 methodology exhibits, 12 glossary entries, and contact matrices for channel partners across 15 regions to support go-to-market planning and investment due diligence.

Extracorporeal Membrane Oxygenation Machine Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 235.96 Million in 2026
Market Size Value By	USD 294.59 Million by 2035
Growth Rate	CAGR of 2.5% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Pumps Oxygenators Heat Exchangers Saturation Monitors By Application : Respiratory Cardiology Extracorporeal Cardiopulmonary Resuscitation
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample